Bioenergy sensing in the brain: The role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases

Cell Cycle

Volumn 10, Issue 20, 2011, Pages 3452-3460

  Amato, Stephen ^a   Man, Heng Ye ^a  

^a Boston University   (United States)

Author keywords

AMPK; Brain; Cell death; Energy; Glucose; Metabolism; Neural development; Neurodegenerative disease; Neuron; Polarization

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

BIOENERGY; BIOGENESIS; BRAIN METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE COURSE; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME STRUCTURE; GLUCOSE TRANSPORT; HUMAN; MEDICAL RESEARCH; METABOLIC DISORDER; MITOCHONDRION; MORPHOGENESIS; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 80055112213     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.20.17953     Document Type: Review

References (118)

1. Blagosklonny MV. Rapamycin and quasi-programmed aging: four years later. Cell Cycle 2010; 9:1859-62; PMID:20436272; DOI:10.4161/ cc.9.10.11872.
2. Blagosklonny MV. Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 2010; 9:683-8; PMID:20139716; DOI:10.4161/cc.9.4.10766.
3. Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Foretz M, Viollet B. Antagonistic control of muscle cell size by AMPK and mTORC1. Cell Cycle 2011; 10:2640-6; PMID:21799304; DOI:10.4161/ cc.10.16.17102.
4. Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MN, et al. Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle 2010; 9:188- 97; PMID:20016287; DOI:10.4161/cc.9.1.10407.
5. Oliveras-Ferraros C, Vazquez-Martin A, Menendez JA. Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cells. Cell Cycle 2009; 8:1633-6; PMID:19372741; DOI:10.4161/ cc.8.10.8406.
6. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108:1167-74; PMID:11602624.
7. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG, 4th, Schlattner U, et al. Activation of the AMPactivated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 2004; 279:43940-51; PMID:15265871; DOI:10.1074/jbc.M404421200.
8. Hudson ER, Pan DA, James J, Lucocq JM, Hawley SA, Green KA, et al. A novel domain in AMPactivated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 2003; 13:861-6; PMID:12747836; DOI:10.1016/S0960-9822(03)00249-5.
9. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 1996; 271:611- 4; PMID:8557660; DOI:10.1074/jbc.271.2.611.
10. Crute BE, Seefeld K, Gamble J, Kemp BE, Witters LA. Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem 1998; 273:35347-54; PMID:9857077; DOI:10.1074/jbc.273.52.35347.
11. Pang T, Xiong B, Li JY, Qiu BY, Jin GZ, Shen JK, et al. Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits. J Biol Chem 2007; 282:495-506; PMID:17088252; DOI:10.1074/jbc.M605790200.
12. Polekhina G, Gupta A, van Denderen BJ, Feil SC, Kemp BE, Stapleton D, et al. Structural basis for glycogen recognition by AMP-activated protein kinase. Structure 2005; 13:1453-62; PMID:16216577; DOI:10.1016/j.str.2005.07.008.
13. Bateman A. The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem Sci 1997; 22:12-3; PMID:9020585; DOI:10.1016/S0968-0004(96)30046-7.
14. Scott JW, Hawley SA, Green KA, Anis M, Stewart G, Scullion GA, et al. CBS domains form energysensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 2004; 113:274-84; PMID:14722619.
15. Xiao B, Heath R, Saiu P, Leiper FC, Leone P, Jing C, et al. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 2007; 449:496-500; PMID:17851531; DOI:10.1038/ nature06161.
16. Jin X, Townley R, Shapiro L. Structural insight into AMPK regulation: ADP comes into play. Structure 2007; 15:1285-95; PMID:17937917; DOI:10.1016/j. str.2007.07.017.
17. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, et al. Structure of mammalian AMPK and its regulation by ADP. Nature 2011; 472:230-3; PMID:21399626; DOI:10.1038/ nature09932.
18. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007; 8:774-85; PMID:17712357; DOI:10.1038/nrm2249.
19. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 2000; 346:659-69; PMID:10698692; DOI:10.1042/0264-6021: 3460659.
20. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 1999; 72:1707-16; PMID:10098881; DOI:10.1046/j.1471-4159.1999.721707.x.
21. Koay A, Woodcroft B, Petrie EJ, Yue H, Emanuelle S, Bieri M, et al. AMPK beta subunits display isoform specific affinities for carbohydrates. FEBS Lett 2010; 584:3499-503; PMID:20637197; DOI:10.1016/j. febslet.2010.07.015.
22. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, et al. Characterization of the AMPactivated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 1996; 271:27879-87; PMID:8910387; DOI:10.1074/jbc.271.44.27879.
23. Davies SP, Helps NR, Cohen PT, Hardie DG. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Calpha and native bovine protein phosphatase-2AC. FEBS Lett 1995; 377:421-5; PMID:8549768; DOI:10.1016/0014- 5793(95)01368-7.
24. Nath N, McCartney RR, Schmidt MC. Yeast Pak1 kinase associates with and activates Snf1. Mol Cell Biol 2003; 23:3909-17; PMID:12748292; DOI:10.1128/MCB.23.11.3909-17.2003.
25. Hong SP, Leiper FC, Woods A, Carling D, Carlson M. Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc Natl Acad Sci USA 2003; 100:8839-43; PMID:12847291; DOI:10.1073/pnas.1533136100.
26. Sutherland CM, Hawley SA, McCartney RR, Leech A, Stark MJ, Schmidt MC, et al. Elm1p is one of three upstream kinases for the Saccharomyces cerevisiae SNF1 complex. Curr Biol 2003; 13:1299- 305; PMID:12906789; DOI:10.1016/S0960- 9822(03)00459-7.
27. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMPactivated protein kinase cascade. J Biol 2003; 2:28; PMID:14511394; DOI:10.1186/1475-4924-2-28.
28. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003; 13:2004-8; PMID:14614828; DOI:10.1016/j.cub.2003.10.031.
29. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005; 2:9-19; PMID:16054095; DOI:10.1016/j. cmet.2005.05.009.
30. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005; 280:29060-6; PMID:15980064; DOI:10.1074/jbc.M503824200.
31. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, et al. Ca2+/calmodulindependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005; 2:21-33; PMID:16054096; DOI:10.1016/j.cmet.2005.06.005.
32. Hemminki A, Avizienyte E, Roth S, Loukola A, Aaltonen LA, Jarvinen H, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Duodecim 1998; 114:667-8; PMID:11524750.
33. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 2004; 101:3329-35; PMID:14985505; DOI:10.1073/pnas.0308061100.
34. Sakamoto K, McCarthy A, Smith D, Green KA, Grahame Hardie D, Ashworth A, et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 2005; 24:1810-20; PMID:15889149; DOI:10.1038/ sj.emboj.7600667.
35. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310:1642-6; PMID:16308421; DOI:10.1126/science.1120781.
36. Barnes AP, Lilley BN, Pan YA, Plummer LJ, Powell AW, Raines AN, et al. LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 2007; 129:549-63; PMID:17482548; DOI:10.1016/j.cell.2007.03.025.
37. Momcilovic M, Hong SP, Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 2006; 281:25336-43; PMID:16835226; DOI:10.1074/jbc.M604399200.
38. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, et al. A pivotal role for endogenous TGFbetaactivated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 2006; 103:17378-83; PMID:17085580; DOI:10.1073/pnas.0604708103.
39. Vilchez D, Ros S, Cifuentes D, Pujadas L, Valles J, Garcia-Fojeda B, et al. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 2007; 10:1407-13; PMID:17952067; DOI:10.1038/nn1998.
40. Weisová P, Concannon CG, Devocelle M, Prehn JH, Ward MW. Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons. J Neurosci 2009; 29:2997-3008; PMID:19261894; DOI:10.1523/JNEUROSCI.0354-09.2009.
41. Fujii N, Jessen N, Goodyear LJ. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 2006; 291:867-77; PMID:16822958; DOI:10.1152/ajpendo. 00207.2006.
42. Abbud W, Habinowski S, Zhang JZ, Kendrew J, Elkairi FS, Kemp BE, et al. Stimulation of AMPactivated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys 2000; 380:347-52; PMID:10933890; DOI:10.1006/abbi.2000.1935.
43. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, et al. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J Cell Sci 2002; 115:2433-42; PMID:12006627.
44. Cidad P, Almeida A, Bolanos JP. Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5′-AMP-activated protein kinase. Biochem J 2004; 384:629-36; PMID:15320870; DOI:10.1042/ BJ20040886.
45. Hoyer S, Henneberg N, Knapp S, Lannert H, Martin E. Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor. Ann NY Acad Sci 1996; 777:374-9; PMID:8624116; DOI:10.1111/j.1749-6632.1996.tb34448.x.
46. Cheng CM, Reinhardt RR, Lee WH, Joncas G, Patel SC, Bondy CA. Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc Natl Acad Sci USA 2000; 97:10236-41; PMID:10954733; DOI:10.1073/pnas.170008497.
47. Bondy CA, Cheng CM. Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004; 490:25-31; PMID:15094071; DOI:10.1016/j. ejphar.2004.02.042.
48. Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, et al. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002; 51:3384-90; PMID:12453890; DOI:10.2337/diabetes. 51.12.3384.
49. Uemura E, Greenlee HW. Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3. Exp Neurol 2006; 198:48-53; PMID:16337941; DOI:10.1016/j.expneurol. 2005.10.035.
50. Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994; 135:1753-61; PMID:7525251; DOI:10.1210/en.135.5. 1753.
51. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959; 234:466-8; PMID:13641241.
52. Bondy CA. Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci 1991; 11:3442-55; PMID:1658250.
53. Myers MG Jr, Sun XJ, White MF. The IRS-1 signaling system. Trends Biochem Sci 1994; 19:289-93; PMID:8048169; DOI:10.1016/0968- 0004(94)90007-8.
54. Saltiel AR, Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 2002; 12:65-71; PMID:11849969; DOI:10.1016/S0962-8924(01)02207- 3.
55. Summers SA, Birnbaum MJ. A role for the serine/ threonine kinase, Akt, in insulin-stimulated glucose uptake. Biochem Soc Trans 1997; 25:981-8; PMID:9388586.
56. Rose AJ, Richter EA. Skeletal muscle glucose uptake during exercise: how is it regulated? Physiology (Bethesda) 2005; 20:260-70; PMID:16024514; DOI:10.1152/physiol.00012.2005.
57. Benomar Y, Naour N, Aubourg A, Bailleux V, Gertler A, Djiane J, et al. Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol- 3-kinase-dependent mechanism. Endocrinology 2006; 147:2550-6; PMID:16497805; DOI:10.1210/en.2005- 1464.
58. Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE. 5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 2001; 276:46912-6; PMID:11598104; DOI:10.1074/jbc.C100483200.
59. Amato S, Liu X, Zheng B, Cantley L, Rakic P, Man HY. AMP-activated protein kinase regulates neuronal polarization by interfering with PI 3-kinase localization. Science 2011; 332:247-51; PMID:21436401; DOI:10.1126/science. 1201678.
60. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996; 270:299-304; PMID:8779952.
61. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, et al. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 1997; 82:219-25; PMID:9029219.
62. Kahn BB, Alquier T, Carling D, Hardie DG. AMPactivated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1:15-25; PMID:16054041; DOI:10.1016/j.cmet.2004.12.003.
63. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967; 242:2278-82; PMID:4290225.
64. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 2000; 88:2219-26; PMID:10846039.
65. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 2002; 99:15983-7; PMID:12444247; DOI:10.1073/ pnas.252625599.
66. Jäger S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC- 1alpha. Proc Natl Acad Sci USA 2007; 104:12017-22; PMID:17609368; DOI:10.1073/pnas.0705070104.
67. Wareski P, Vaarmann A, Choubey V, Safiulina D, Liiv J, Kuum M, et al. PGC-1{alpha} and PGC- 1{beta} regulate mitochondrial density in neurons. J Biol Chem 2009; 284:21379-85; PMID:19542216; DOI:10.1074/jbc.M109.018911.
68. Palacios OM, Carmona JJ, Michan S, Chen KY, Manabe Y, Ward JL, 3rd, et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC- 1alpha in skeletal muscle. Aging (Albany NY) 2009; 1:771-83; PMID:20157566.
69. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA 2007; 104:7217-22; PMID:17438283; DOI:10.1073/ pnas.0610068104.
70. Onyango IG, Lu J, Rodova M, Lezi E, Crafter AB, Swerdlow RH. Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochim Biophys Acta 2010; 1802:228-34.
71. Yu L, Yang SJ. AMP-activated protein kinase mediates activity-dependent regulation of peroxisome proliferator-activated receptor gamma coactivator- 1alpha and nuclear respiratory factor 1 expression in rat visual cortical neurons. Neuroscience 2010; 169:23-38; PMID:20438809; DOI:10.1016/j. neuroscience. 2010.04.063.
72. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 2007; 447:1017-20; PMID:17486097; DOI:10.1038/nature05828.
73. Spasić MR, Callaerts P, Norga KK. Drosophila alicorn is a neuronal maintenance factor protecting against activity-induced retinal degeneration. J Neurosci 2008; 28:6419-29; PMID:18562613; DOI:10.1523/JNEUROSCI.1646-08.2008.
74. Dasgupta B, Milbrandt J. AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev Cell 2009; 16:256-70; PMID:19217427; DOI:10.1016/j. devcel.2009.01.005.
75. McLear JA, Garcia-Fresco G, Bhat MA, Van Dyke TA. In vivo inactivation of pRb, p107 and p130 in murine neuroprogenitor cells leads to major CNS developmental defects and high seizure rates. Mol Cell Neurosci 2006; 33:260-73; PMID:16979903; DOI:10.1016/j.mcn.2006.07.012.
76. Zang Y, Yu LF, Nan FJ, Feng LY, Li J. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by downregulating phospho-retinoblastoma protein and cyclin D. J Biol Chem 2009; 284:6175-84; PMID:19144636; DOI:10.1074/jbc. M806887200.
77. Ropireddy D, Scorcioni R, Lasher B, Buzsaki G, Ascoli GA. Axonal morphometry of hippocampal pyramidal neurons semi-automatically reconstructed after in vivo labeling in different CA3 locations. Brain Struct Funct 2011; 216:1-15; PMID:21128083; DOI:10.1007/s00429-010-0291-8.
78. Arimura N, Kaibuchi K. Neuronal polarity: from extracellular signals to intracellular mechanisms. Nat Rev Neurosci 2007; 8:194-205; PMID:17311006; DOI:10.1038/nrn2056.
79. Amato S. AMPK links cellular bioenegy to the decision making of axon initiation in neurons. Cell Logist 2011; 1:103-5; DOI:10.4161/cl.1.3.16815.
80. Shi SH, Jan LY, Jan YN. Hippocampal neuronal polarity specified by spatially localized mPar3/ mPar6 and PI 3-kinase activity. Cell 2003; 112:63- 75; PMID:12526794; DOI:10.1016/S0092- 8674(02)01249-7.
81. Williams T, Courchet J, Viollet B, Brenman JE, Polleux F. AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress. Proc Natl Acad Sci USA 2011; 108:5849-54; PMID:21436046; DOI:10.1073/pnas.1013660108.
82. Shelly M, Cancedda L, Heilshorn S, Sumbre G, Poo MM. LKB1/STRAD promotes axon initiation during neuronal polarization. Cell 2007; 129:565-77; PMID:17482549; DOI:10.1016/j.cell.2007.04.012.
83. Guo MF, Yu JZ, Ma CG. Mechanisms related to neuron injury and death in cerebral hypoxic ischaemia. Folia Neuropathol 2011; 49:78-87; PMID:21845535.
84. Northington FJ, Chavez-Valdez R, Martin LJ. Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 2011; 69:743-58; PMID:21520238; DOI:10.1002/ana.22419.
85. Narbonne P, Roy R. Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature 2009; 457:210-4; PMID:19052547; DOI:10.1038/nature07536.
86. Kewalramani G, Puthanveetil P, Wang F, Kim MS, Deppe S, Abrahani A, et al. AMP-activated protein kinase confers protection against TNF{alpha}- induced cardiac cell death. Cardiovasc Res 2009; 84:42-53; PMID:19477967; DOI:10.1093/cvr/ cvp166.
87. Culmsee C, Monnig J, Kemp BE, Mattson MP. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 2001; 17:45-58; PMID:11665862; DOI:10.1385/JMN:17:1:45.
88. Kuramoto N, Wilkins ME, Fairfax BP, Revilla-Sanchez R, Terunuma M, Tamaki K, et al. Phosphodependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase. Neuron 2007; 53:233-47; PMID:17224405; DOI:10.1016/j.neuron.2006.12.015.
89. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005; 280:20493-502; PMID:15772080; DOI:10.1074/ jbc.M409985200.
90. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD. Neuroprotective effects of adenosine monophosphateactivated protein kinase inhibition and gene deletion in stroke. Stroke 2007; 38:2992-9; PMID:17901380; DOI:10.1161/ STROKEAHA.107.490904.
91. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S. AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 2009; 109:17-23; PMID:19393004; DOI:10.1111/j.1471- 4159.2009.05916.x.
92. Garcia-Gil M, Pesi R, Perna S, Allegrini S, Giannecchini M, Camici M, et al. 5′-aminoimidazole- 4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 2003; 117:811-20; PMID:12654334; DOI:10.1016/S0306- 4522(02)00836-9.
93. Salminen A, Kaarniranta K, Haapasalo A, Soininen H, Hiltunen M. AMP-activated protein kinase: a potential player in Alzheimer's disease. J Neurochem 2011; 118:460-74; PMID:21623793; DOI:10.1111/ j.1471-4159.2011.07331. x.
94. Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF. Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets 2010; 11:1193-206; PMID:20840064.
95. Hoyer S. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp Gerontol 2000; 35:1363-72; PMID:11113614; DOI:10.1016/S0531- 5565(00)00156-X.
96. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992; 31:119-30; PMID:1349466; DOI:10.1002/ana.410310202.
97. Chen Y, Zhou K, Wang R, Liu Y, Kwak YD, Ma T, et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via upregulating BACE1 transcription. Proc Natl Acad Sci USA 2009; 106:3907-12; PMID:19237574; DOI:10.1073/pnas.0807991106.
98. Won JS, Im YB, Kim J, Singh AK, Singh I. Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis. Biochem Biophys Res Commun 2010; 399:487-91; PMID:20659426; DOI:10.1016/j. bbrc.2010.07.081.
99. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 2010; 285:9100-13; PMID:20080969; DOI:10.1074/jbc. M109.060061.
100. Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloidbeta peptides. J Biol Chem 2005; 280:37377-82; PMID:16162502; DOI:10.1074/jbc.M508246200.
101. Vingtdeux V, Chandakkar P, Zhao H, d'Abramo C, Davies P, Marambaud P. Novel synthetic smallmolecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB J 2011; 25:219-31; PMID:20852062; DOI:10.1096/ fj.10-167361.
102. Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 2009; 15:112-9; PMID:19246243; DOI:10.1016/j.molmed. 2009.01.003.
103. Johnson GV, Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 2004; 117:5721-9; PMID:15537830; DOI:10.1242/ jcs.01558.
104. Thornton C, Bright NJ, Sastre M, Muckett PJ, Carling D. AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid beta-peptide exposure. Biochem J 2011; 434:503-12; PMID:21204788; DOI:10.1042/BJ20101485.
105. Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 1997; 89:297-308; PMID:9108484; DOI:10.1016/ S0092-8674(00)80208-1.
106. Wang JW, Imai Y, Lu B. Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. J Neurosci 2007; 27:574-81; PMID:17234589; DOI:10.1523/JNEUROSCI.5094-06.2007.
107. Ju TC, Chen HM, Lin JT, Chang CP, Chang WC, Kang JJ, et al. Nuclear translocation of AMPK- {alpha}1 potentiates striatal neurodegeneration in Huntington's disease. J Cell Biol 2011; 194:209-27; PMID:21768291; DOI:10.1083/jcb.201105010.
108. Choi JS, Park C, Jeong JW. AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Biochem Biophys Res Commun 2010; 391:147-51; PMID:19903456; DOI:10.1016/j. bbrc.2009.11.022.
109. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331:456- 61; PMID:21205641; DOI:10.1126/science.1196371.
110. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; DOI:10.1038/ncb2152.
111. Pellerin L, Magistretti PJ. How to balance the brain energy budget while spending glucose differently. J Physiol 2003; 546:325; PMID:12527720; DOI:10.1113/jphysiol.2002.035105.
112. Dhar SS, Wong-Riley MT. Coupling of energy metabolism and synaptic transmission at the transcriptional level: role of nuclear respiratory factor 1 in regulating both cytochrome c oxidase and NMDA glutamate receptor subunit genes. J Neurosci 2009; 29:483-92; PMID:19144849; DOI:10.1523/ JNEUROSCI.3704-08.2009.
113. Potter WB, O'Riordan KJ, Barnett D, Osting SM, Wagoner M, Burger C, et al. Metabolic regulation of neuronal plasticity by the energy sensor AMPK. PLoS ONE 2010; 5:8996; PMID:20126541; DOI:10.1371/journal.pone.0008996.
114. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, et al. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 2004; 279:12005-8; PMID:14742438; DOI:10.1074/jbc.C300557200.
115. Lim CT, Kola B, Korbonits M. AMPK as a mediator of hormonal signalling. J Mol Endocrinol 2010; 44:87-97; PMID:19625456; DOI:10.1677/JME-09-0063.
116. Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S. Role of hypothalamic AMP-kinase in food intake regulation. Nutrition 2008; 24:786-90; PMID:18725075; DOI:10.1016/j.nut.2008.06.002.
117. Ramamurthy S, Ronnett GV. Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J Physiol 2006; 574:85-93; PMID:16690704; DOI:10.1113/jphysiol.2006.110122.
118. Bright NJ, Thornton C, Carling D. The regulation and function of mammalian AMPK-related kinases. Acta Physiol (Oxf) 2009; 196:15-26; PMID:19245655; DOI:10.1111/j.1748-16.2009.01971.x.